Fabrazyme® (agalsidase beta) safety profile
Find out more about the safety and tolerability profile for Fabrazyme®.
This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.
Find out more about the safety and tolerability profile for Fabrazyme®.
Explore the results and evidence supporting Fabrazyme® and how it was studied through several clinical trials.
Explore the results and evidence supporting Nexviadyme® and how it was studied through several clinical trials.
A multi-channel learning journey providing knowledge, training and practical tools to empower MS nurses to implement change.
This course is intended for healthcare professionals in Great Britain (England, Scotland, Wales) only.
Slides and recording of Diabetes UK 2024 - in collaboration with Diabetes Specialist Nurse Forum UK
Slides and recording of Diabetes UK 2024 - in collaboration with Diabetes Specialist Nurse Forum UK
MAT-XU-2305062 (v1.0) - Date of preparation: November 2023